CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 7,615 shares at an average $194.59 ($1,481,811)
- 4 Open-market sale EVP, Chief Financial Officer sold 977 shares at an average $194.59 ($190,113)
- 4 Open-market sale EVP, Chief Commercial Officer sold 1,476 shares at an average $194.59 ($287,215)
- 4 Open-market sale President sold 2,392 shares at an average $194.59 ($465,464)
- 4 Open-market sale CMO & EVP Dev & Med Affairs sold 4,294 shares at an average $197.12 ($846,450)
- 4 Open-market sale EVP, CLO & Secretary sold 3,500 shares at $210.00 ($735,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CMO & EVP Dev & Med Affairs sold 18,072 shares at $200.00 ($3,614,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 47 · 936 filings